Literature DB >> 3023447

Intravascular release of intact cellular fibronectin during oxidant-induced injury of the in vitro perfused rabbit lung.

J H Peters, M H Ginsberg, B P Bohl, L A Sklar, C G Cochrane.   

Abstract

Fibronectin (Fn) is produced by cells in blood vessels at inflammatory sites in vivo. Fn release into the circulation thus may be a marker for vascular injury. In support of this, we found that oxidant-induced vascular injury of isolated perfused rabbit lungs caused elevated circulating Fn levels. Western blot analysis indicated that Fn released from the injured blood vessels was intact, dimeric, and possessed electrophoretic mobility identical with Fn produced by fibroblasts. Unlike Fn isolated from rabbit plasma, Fn derived from lung perfusate or produced by fibroblasts reacted with antibodies raised to a synthetic peptide containing sequences from the extra type III Fn domain that is transcribed in fibroblasts but not hepatocytes. Vascular injury by protease was also associated with intravascular release of Fn, but with cleavage. Oxidant-induced vascular injury causes release of tissue-derived Fn, which can be distinguished from plasma Fn by its size and content of antigenic determinants of the extra type III domain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023447      PMCID: PMC423927          DOI: 10.1172/JCI112752

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Characterization of a major fibroblast cell surface glycoprotein.

Authors:  K M Yamada; D H Schlesinger; D W Kennedy; I Pastan
Journal:  Biochemistry       Date:  1977-12-13       Impact factor: 3.162

4.  Enzyme immunoassay ELISA and EMIT.

Authors:  E Engvall
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

5.  Fibronectin synthesis by epithelial crypt cells of rat small intestine.

Authors:  A Quaroni; K J Isselbacher; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

6.  Serum fibronectin is elevated during normobaric and hyperbaric oxygen exposure in rats.

Authors:  M Glass; J E Kaplan; E Macarak; S J Aukberg; A B Fisher
Journal:  Am Rev Respir Dis       Date:  1984-08

7.  Cold-insoluble globulin (fibronectin, LETS protein) in normal and diseased human glomeruli: papain-sensitive attachment to normal glomeruli and deposition in crescents.

Authors:  E E Pettersson; R B Colvin
Journal:  Clin Immunol Immunopathol       Date:  1978-12

8.  Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory-distress syndrome.

Authors:  C T Lee; A M Fein; M Lippmann; H Holtzman; P Kimbel; G Weinbaum
Journal:  N Engl J Med       Date:  1981-01-22       Impact factor: 91.245

9.  Fibroblast cellular and plasma fibronectins are similar but not identical.

Authors:  K M Yamada; D W Kennedy
Journal:  J Cell Biol       Date:  1979-02       Impact factor: 10.539

10.  Synthesis of fibronectin by cultured human endothelial cells.

Authors:  E A Jaffe; D F Mosher
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

View more
  11 in total

1.  Relationship of human macrophage agglutination factor to other fibronectins.

Authors:  H P Godfrey; L S Canfield; M Haak-Frendscho; J Melancon-Kaplan; E J Brown; A P Kaplan
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

2.  Fibronectin fragments containing the RGDS cell-binding domain mediate monocyte migration into the rabbit lung. A potential mechanism for C5 fragment-induced monocyte lung accumulation.

Authors:  D E Doherty; P M Henson; R A Clark
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

3.  Recipient-derived EDA fibronectin promotes cardiac allograft fibrosis.

Authors:  Adam J Booth; Sherri C Wood; Ashley M Cornett; Alyssa A Dreffs; Guanyi Lu; Andrés F Muro; Eric S White; D Keith Bishop
Journal:  J Pathol       Date:  2012-01-04       Impact factor: 7.996

4.  Cellular fibronectin response to supervised moderate aerobic training in patients with type 2 diabetes.

Authors:  Ahmad H Alghadir; Sami A Gabr; Einas Al-Eisa
Journal:  J Phys Ther Sci       Date:  2016-04-28

5.  Identification of a third region of cell-specific alternative splicing in human fibronectin mRNA.

Authors:  A Gutman; A R Kornblihtt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

6.  Leukocyte elastase-independent proteolysis of gelatin-bound fibronectin by inflammatory macrophages.

Authors:  I Daudi; P W Gudewicz; T M Saba; E Cho; M B Frewin
Journal:  Inflammation       Date:  1991-12       Impact factor: 4.092

7.  Intraocular and plasma levels of cellular fibronectin in patients with uveitis and diabetes mellitus.

Authors:  K Probst; R Fijnheer; P Schellekens; A Rothova
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

8.  Correlations between plasma levels of a fibronectin isoform subpopulation and C-reactive protein in patients with systemic inflammatory disease.

Authors:  John H Peters; Tammy Greasby; Nancy Lane; Anthony Woolf
Journal:  Biomarkers       Date:  2009-06       Impact factor: 2.658

9.  Changes in plasma fibronectin isoform levels predict distinct clinical outcomes in critically ill patients.

Authors:  John H Peters; Mark N Grote; Nancy E Lane; Richard J Maunder
Journal:  Biomark Insights       Date:  2011-05-29

10.  Detachment of cultured cells from the substratum induced by the neutrophil-derived oxidant NH2Cl: synergistic role of phosphotyrosine and intracellular Ca2+ concentration.

Authors:  T Y Nakamura; I Yamamoto; H Nishitani; T Matozaki; T Suzuki; S Wakabayashi; M Shigekawa; K Goshima
Journal:  J Cell Biol       Date:  1995-10       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.